3-D snapshot of protein highlights potential drug target for breast cancer
2015-03-17
(Press-News.org) The genome of a cell is under constant attack, suffering DNA damage that requires an army of repair mechanisms to keep the cell healthy and alive. Understanding the behavior of the enzymes defending these assaults helps determine how - and where - cancer gets its foothold and flourishes. New research published in an Advance Online Publication of Nature Structural & Molecular Biology shows that one of these enzymes - human DNA polymerase theta (POLQ) - may be a promising drug therapy target for inhibiting breast cancer.
"The human genome encodes more than 15 different polymerases, which are the essential enzymes that copy our genetic material," says Karl Zahn, Ph.D., University of Vermont postdoctoral associate and first author on the study. "POLQ is known to serve a specialized role - it can perform some tasks that other polymerases are unable to do, including the repair of certain toxic double-strand breaks in the DNA, which can induce genomic instability if left unrepaired."
This genomic instability can sometimes lead to cancer, especially the types of cancer that are most difficult to treat.
Using X-ray crystallography, Zahn and University of Vermont structural biologist Sylvie Doublié, Ph.D., and colleagues determined the first crystal structures of POLQ - recently highlighted as the only DNA polymerase overexpressed in certain breast and ovarian cancers - providing a visual of the DNA repair process.
"The field focused on this enzyme is evolving," says Doublié, senior author on the paper, which is one of several POLQ-related studies published in the last month. The team's work provides a first step in determining how to feasibly pursue POLQ as a cancer drug target.
"Having this new structure really helps inform this process," says Doublié.
While already found in breast, ovarian, lung and oral cancers, POLQ is believed to play a role in a number of additional cancers, so the impact of the group's finding could be far-reaching in terms of new therapies.
Doublié and Zahn's coauthor Richard Wood, Ph.D., of the Department of Epigenetics & Molecular Carcinogenesis at the University of Texas MD Anderson Cancer Center, and colleagues are in the process of examining candidate drug-like molecules that might act specifically on POLQ without inhibiting other necessary polymerases to limit side effects in cancer patients.
In addition to Doublié, a professor of microbiology and molecular genetics, Zahn, and Wood, coauthors on the study include April Averill, University of Vermont senior research technician in microbiology and molecular genetics, and Pierre Aller, Ph.D., of Diamond Light Source, Didcot, Oxfordshire, UK.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-17
What's in store for the future of industrial bioprocessing for medical therapies, which involves the use of living organisms or cells to create drugs or other agents? Will the batch or continuous bioprocessing platform dominate biomanufacturing of human therapeutics down the road? Three pioneers in the field address these questions in an upcoming issue of Biotechnology and Bioengineering.
With batch bioprocessing, components are transferred as a batch from one holding vessel or processing equipment to the next, while with continuous bioprocessing, there is a continuous ...
2015-03-17
URBANA, Ill. - While many recent studies have documented that agricultural producers must significantly increase yields in order to meet the food, feed, and fuel demands of a growing population, few have given practical solutions on how to do this. Crop science researchers at the University of Illinois interested in determining and reducing corn yield gaps are addressing this important issue by taking a systematic approach to the problem.
A recent study from the Illinois Crop Physiology Laboratory, led by Fred Below, a U of I crop physiologist, provides the first estimate ...
2015-03-17
Previous calculations may have overestimated the importance of HIV transmission from recently infected individuals ("acute phase infectivity") in driving HIV epidemics, according to an article published by Steve Bellan of The University of Texas at Austin, and colleagues in this week's PLOS Medicine.
The lower estimates of acute phase infectivity suggest that recently infected individuals--who have not had the chance to start antiretroviral treatment--although still more infectious on average than those in the chronic stage of infection, are not as likely to infect others ...
2015-03-17
Overpopulation, the greenhouse effect, warming temperatures and overall climate disruption are all well recognized as a major threat to the ecology and biodiversity of the Earth. The issue of mankind's negative impact on the environment, albeit hotly debated and continuously present in the public eye, still only leads to limited policy action.
Urgent action is required, insist Paul Cruzten and Stanislaw Waclawek, the authors of "Atmospheric Chemistry and Climate in the Anthropocene", published in open access in the new Chemistry-Didactics-Ecology-Metrology.
In their ...
2015-03-17
TORONTO, March 17, 2015 - A group of York University investigators and their international counterparts have jointly created a database of lake surface temperatures, to help study ecological effects of climate change.
"There has been a significant need to put together a database like this, considering the rapid warming of lakes," observes Professor Sapna Sharma in the Department of Biology in the Faculty of Science who led the international effort.
As part of the Global Lake Temperature Collaboration (GLTC) project, Sharma and several of her undergraduate students, Anam ...
2015-03-17
AUSTIN, Texas - People who recently have been infected with HIV may not be as highly infectious as previously believed, a finding that could improve global efforts to prevent HIV transmission and save lives. In particular, the finding bolsters the strategy of treating patients with antiretroviral drugs before the onset of AIDS to prevent transmission.
Mathematical epidemiologists Steve Bellan, a postdoctoral researcher at The University of Texas at Austin, and Lauren Ancel Meyers, a biology professor at the university, authored the paper with researchers from McMaster ...
2015-03-17
Scientists in a collaboration led by Dai Takei of the RIKEN SPring-8 Center in Japan have, for the first time, examined a detailed 'time lapse' X-ray image of the expansion of a classical nova explosion using the GK Persei nova -- a binary star system which underwent a nova explosion in 1901.
Through this work, they hope to gain a better understanding of the expansion of gases in the universe, including not only in classical novae but also in supernovae--tremendous stellar explosions that are believed to be responsible for the creation of heavy elements such as uranium ...
2015-03-17
Vitamin D may play a vital role in the prevention and treatment of diseases associated with aging, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing (MNSON). These findings were published in the latest issue of the Journal of Aging and Gerontology.
Researchers reviewed evidence that suggests an association between vitamin D deficiency and chronic diseases associated with aging such as cognitive decline, depression, osteoporosis, cardiovascular disease, high blood pressure, Type 2 diabetes and cancer.
"Vitamin D deficiency is a ...
2015-03-17
Hamilton, ON (March 17, 2015) - It's long been known that obese men are more likely to develop type two diabetes than obese women, but researchers at McMaster University have discovered it may be related to a difference between the sexes in the activity of a protein in the muscle.
As people become overweight, their skeletal muscle develops insulin resistance that can lead to type two diabetes. In a paper published by Scientific Reports today, the research team found the activity of this protein, called PTEN (for Phosphatase and tensin homolog deleted on chromosome 10), ...
2015-03-17
CORVALLIS, Ore. - Young, inexperienced drivers have always gotten into more automobile accidents, but if you add in a lot of distractions, it's a recipe for disaster - and a new Pacific Northwest research program is learning more about these risks while identifying approaches that may help reduce them.
Distractions have been an issue since the age of the Model T, whether a driver was eating a sandwich or talking to a passenger. But the advent of cell phones, text messaging and heavy urban traffic has taken those distractions to a historic level, say researchers, who ...
LAST 30 PRESS RELEASES:
[Press-News.org] 3-D snapshot of protein highlights potential drug target for breast cancer
